Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (OTCQX: $CURLF),
(NASDAQ: $ACB) and (OTC: $HEMP)
September 7th, 2023 (Investorideas.com
Newswire), investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/090723-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/09071CURLF-ACB-HEMP.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we go over a few public
company announcements, the potential policy changes around recreational
cannabis use for the RCMP, a new study which suggests cannabis legalisation has
led to an increase in cannabis-involved traffic injury emergency department
visits and the continued rise of cannabis stocks on the speculation of cannabis
rescheduling in the U.S.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced the launch of Zero Proof, a new
brand of THC drinkables in fast-acting, sessionable and easy-to-use formats.
The brand's inaugural product offering, Squeeze, is now available at all
Curaleaf locations in Illinois and will be followed by additional SKUs in the
coming months.
Zero Proof Squeeze follows Select's popular
THC-infused beverage enhancer, Select Squeeze, originally launched in March
2021. While similar in functionality and effect, Zero Proof Squeeze has been
reformulated with natural sweetener to provide a significantly lighter taste
and balanced flavour profile for enhanced mixability. The beverage complement
offers a uniquely controllable and customizable experience with an easy-to-pour
dispenser and compact design delivering 2.5mg THC per dose for discreet
enjoyment on the go.
Utilising nanotechnology, Zero Proof Squeeze
provides a truer-to-flower experience with effects felt in as little as 15-30
minutes, significantly faster than traditional edibles. By turning cannabis oil
into tiny water-soluble molecules, the THC compounds dissolve evenly into any
beverage and are more rapidly and efficiently absorbed into the bloodstream. At
launch, four delicious, low calorie and gluten-free flavours will be available
including Dash of Cherry, Dash of Orange, Dash of Lime and Dash of Sweet.
"Zero Proof exemplifies our commitment
to providing high-quality, consistent consumer products in familiar and
approachable formats that model traditional consumer packaged goods," said
Matt Darin, CEO of Curaleaf. "Curaleaf has been on the forefront of
creating sophisticated cannabis experiences which we believe will ultimately
redefine the way people socialise. We're proud to bring Zero Proof Squeeze to
our patients and customers in Illinois first before expanding to additional
markets."
According to a new Gallup poll, the rate of alcohol consumption
in the U.S. continues to decline with 62% of adults under age 35 reporting they
drink alcohol, down 10% from two decades ago. Zero Proof is the latest addition
to Curaleaf's brand portfolio that seeks to redefine how people socialise by
delivering a fast-acting, sessionable alternative to alcohol.
Aurora
Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced an expansion of its hemp-derived CBD
portfolio into Brazil. In partnership with Herbarium, the leading Brazilian
full-spectrum, single-source 3% CBD oil, under the Herbarium brand. Now
available under the direction of medical doctors, patients across Brazil have
access to high quality CBD as part of their healthcare.
"We are proud to continue our
international expansion and bring quality CBD products to Brazilians alongside
our partner, Herbarium, a trusted brand in the market," says Andre Jerome,
EVP of Global Business Development at Aurora Cannabis. "Brazil has strong
growth potential, and we look forward to leveraging our leadership in the
market to further unlock key opportunities in South America."
The CBD oil is produced at Aurora's
production facility in Uruguay, one of the only GMP-certified cannabis
processing facilities in the country. Known for quality and reliability, Aurora
is a leading global supplier of a complete portfolio of cannabis products,
including CBD offerings, to 13 countries internationally.company in herbal
medicine, Aurora will launch the company's
Hemp,
Inc. (OTC:HEMP) has been cited as one of the key players as
the future scope of industrial hemp is set to reach $18.6 billion by 2027.
According to the latest report (published September 1, 2023)
Industrial Hemp Market Industry Increasing Demand, Emerging Trends, Growth, and
Future Scope by 2027 provides a quantitative analysis of market segments and
current trends, and Hemp, Inc. is profiled as one of the key players driving
the market.
The industrial hemp industry is a rapid,
eco-conscious marvel and according to one common denominator of recent reports, hemp-based products will
continue to have significant growth over the next few years which will
undoubtedly bring more opportunities to companies well-positioned in the
industry.
Hemp, Inc.’s e-portal (www.hempinc.com) to its CBD products is primed
and poised to capture a large share of the marketplace, not just domestically
but globally if the hemp industry continues to evolve at this rate. Report after report, as another one mentioned in a previous
press release, is seeing a surge in the “younger population toward organic and
natural products' ' which is anticipated to drive the demand for hemp-based
products globally. There’s no doubt Hemp, Inc. has a superb lineup of
CBD/CBG/CBN products so the Company is well-positioned to grab a sizable
portion of that market share. Hemp, Inc.’s products include a CBD-CBG Topical
Pain Relief Roll-on (THC-free with 1,460mg of CBD and 630mg of CBG totaling
2,090mg of cannabinoids in 5ml), CBD/CBG Natural Coffee Enhancers, CBD/CBG
Tinctures, and, CBDa/CBGa/CBD/CBG/CBN Capsules.
The Company also discovered its grounded
kenaf hemp blend makes the perfect substrate to grow healthy and/or medicinal
mushrooms and has the capability to make and/or provide the raw materials to
produce hemp-based products such as hempcrete, horse bedding, hemp bioplastics,
and more. Needless to say, Hemp, Inc. continues to have a strong foothold in
the market with an invaluable roster of manufacturers and vendors across the
country and abroad to see meteoric growth curves on a domestic and
international scale.
“Industrial hemp or hemp is a variety of
Cannabis sativa plant species that is grown especially for commercial purposes.
Industrial hemp is a fast-growing, environmentally friendly plant with a low
cost to produce. It is also one of the multipurpose and sustainable crops in
the world. Moreover, industrial hemp can be refined into a variety of
commercial items such as rope, paper, clothing, textiles, insulation, paint,
biodegradable plastics, food, biofuel, and animal feed.” (Source)
In recent news, the RCMP has suggested easing a
policy that requires front-line officers and many other employees to refrain
from recreational cannabis use for four weeks before duty.
A change to the five-year-old policy could
bolster recruitment of new officers by bringing the Mounties in line with
police forces that have much less restrictive policies on pot use
An internal RCMP briefing note, obtained by
The Canadian Press through the Access to Information Act, recommends a 24-hour
restriction on cannabis use before reporting to work, with some exceptions.
RCMP spokeswoman Robin Percival says the
current policy is under review but no final decision has been made.
The policy took effect in 2018 when Canada
legalised recreational cannabis.
It requires RCMP employees in
safety-sensitive positions to refrain from non-medicinal
cannabis use 28 days before reporting to
work.
The policy covers a wide array of employees,
from officers and reservists to telecommunication operators and firearm
technicians.
The RCMP says it reviewed all aspects of
its operations in developing the 2018 policy on substance use. It reasoned that
members work across Canada in a unique environment, including as first
responders, in rural and remote communities and can be called back for duty at
any time.
“All RCMP employees must be fit for duty
when reporting for work, which includes not being impaired by alcohol or
drugs,” says a notice on the RCMP website explaining the policy.
“Science shows that cannabis can intoxicate
beyond initial consumption and that there are no established safe limits or
data on how it affects performance. Without established scientific information
about cannabis impairment, the RCMP policy is taking a careful approach at this
time, to ensure workplace and public safety is maintained at all times.”
In other news, according to a new study, which I highly
recommend you read in full detail to determine the veracity of the study,
suggests that over a span of 11 years, annual rates of Ontario emergency
department visits for cannabis-related traffic
injuries surged dramatically.
The study, published Wednesday in JAMA Network Open,
looked at cannabis involvement in emergency room visits for traffic injuries
between 2010 and 2021 in Ontario. It also examined shifts in cannabis
consumption and driving habits following federal legalisation in 2018.
“Our data is raising concern about a
growing problem of cannabis impairment and severe road injuries,” said lead
author, Dr. Daniel Myran, who is also a fellow at the Bruyère Research
Institute and with the University of Ottawa’s Department of Family Medicine.
“Since 2010 there has been a very, very
large increase in cannabis involvement and traffic injury visits in Ontario.”
When the study is looked at under closer examination
we do see that there is no data on which percentage of the 7564 alcohol related
traffic injury ED visits and the 426 cannabis related traffic injury ED visits
had any crossover. One of the issues when looking at cannabis as an impairment
for driving, or in any testing situation, is the fact that cannabis remains in
the blood for up to 90 days. This is an issue I have discussed often on the
podcast and one which is well known in the cannabis testing world.
Another issue which has come up often when
such statistics surrounding cannabis are brought up in the media or in studies
is we often intentionally omit the fact that many of these cannabis related
traffic injuries, also have alcohol in their system, and that it is actually
the alcohol which leads to further coordination and reflex impairment.
A hypothetical scenario, which has occurred
many times in such data sets, is someone who gets in a drunk driving accident
also still has high levels of THC in their system from consumption that is
sometimes days previous to the accident. The report is then filed twice, once
as a cannabis incident and once again as an alcohol related incident. There has
also been occasion where it is only cited as a cannabis related incident.
Again to any interested in the data
provided by this study, I suggest a thorough read.
Finally, we continue to see Cannabis stocks, including Canopy Growth (CGC),
Curaleaf Holdings (CURLF), and Leafly Holdings (LFLY)
to name but a few, got a boost in trading after media reports, as well as a Marijuana Moment
report stated that President Biden has been “very clear” about the “the
legalisation of marijuana for medical purposes.”
This is all based on the news surrounding
the HHS recommending a “rescheduling” of cannabis from a Schedule I drug to a
Schedule III status which we covered in our previous podcast.
While this speculation is currently a boon
for the investment side of the industry, investors and supporters of cannabis should
be cautious of becoming overly optimistic given the many times in the past
there has been speculation surrounding the SAFE banking act and cannabis
decriminalisation which did not materialise. The fact that the Biden
administration has come under heavy criticism for not acting enough when it
comes to cannabis regulations and is heading into an election year should also
be taken into consideration.
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and that
this podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
To
hear more Investorideas.com podcasts visit:
https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About Investorideas.com - Big Investing Ideas
Investorideas.com is a
platform for investing ideas. We publish breaking stock news, stock research,
guest posts and create original top rated investing podcasts, plus sector tag
articles featuring up and coming companies and industry leaders. Investor
Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move
Podcast ,
Cleantech and Climate Change Podcast,
Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and
tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and
wellness, mining, oil and gas, sports and water. Public companies within the
sectors we cover can use our news publishing and content creation services to
help tell their story to interested investors.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except
where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment